Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-α in SK-BR-3 breast cancer cells

Cancer Letters

Volumn 115, Issue 1, 1997, Pages 63-72

  Flicker, Sabine H ^a   Schneider, Sonja M ^a   Offterdinger, Martin ^a   Dittrich, Evelyn ^a   Fazeny, Barbara ^a   Valenta, Rudolf ^a   Huber, Heinz ^a   Dittrich, Christian ^b   Grunt, Thomas W ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

c erbB; Epidermal growth factor; Heregulin; Retinoic acid receptors; Tyrosine phosphorylation

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR; HERBIMYCIN A; MESSENGER RNA; NEU DIFFERENTIATION FACTOR; ORTHOVANADIC ACID; PROTEIN TYROSINE KINASE; RETINOIC ACID RECEPTOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, ERBB-2; RECEPTORS, RETINOIC ACID; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031149049     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04715-0     Document Type: Article

References (26)

1. [1] Roman, S.D., Clarke, C.L., Hall, R.E., Alexander, I.E. and Sutherland, R.L. (1992) Expression and regulation of retinoic acid receptors in human breast cancer cells, Cancer Res., 52, 2236-2242.
2. [2] van der Burg, B., van der Leede, B.M., Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S.W. and van der Saag, P.T. (1993) Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function, Mol. Cell. Endocrinol., 91, 149-157.
3. [3] Carraway, K.L. III and Cantley, L.C. (1994) A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling, Cell, 78, 5-8.
4. [4] Grunt, T.W. and Huber, H. (1994) The family of c-erbB genes: from basic research to clinical oncology, Onkologie, 17, 346-357.
5. HER2 signal transduction in breast cancer cells, J. Biol. Chem., 266, 14300-14305.
6. [6] Hudziak, R.M., Lewis, G.D., Winget, M., Fendley, B.M., Shepard, H.M. and Ullrich, A. (1989) Monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor, Mol. Cell. Biol., 9, 1165-1172.
7. [7] Leroy, P., Krust, A., Zelent, A., Mendelsohn, C., Garnier, J.-M., Kastner, P., Dierich, A. and Chambon, P. (1991) Multiple isoforms of the mouse retinoic acid receptor α are generated by alternative splicing and differential induction by retinoic acid, EMBO J., 10, 59-69.
8. [8] Uehara, Y., Murakami, Y., Suzukake-Tsuchiya, K., Moriya, Y., Sano, H., Shibata, K. and Omura, S. (1988) Effects of herbimycin derivates on src oncogene function in relation to antitumor activity, J. Antibiot. (Tokyo), 41, 831-834.
9. [9] Miller, P., DiOrio, C., Moyer, M., Schnur, R.C., Bruskin, A., Cullen, W. and Moyer, J.D. (1994) Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins, Cancer Res., 54, 2724-2730.
10. [10] Ramasarma, T. and Crane, F.L. (1981) Does vanadium play a role in cellular regulation?, Curr. Top. Cell Regul., 20, 247-301.
11. [11] Grunt, T.W., Saceda, M., Martin, M.-B., Lupu, R., Dittrich, E., Krupitza, G., Harant, H., Huber, H. and Dittrich, C. (1995) Bidirectional interactions between the estrogen receptor and the c-erbB-2 signaling pathways: heregulin inhibits estrogenic effects in breast cancer cells, Int. J. Cancer, 63, 560-567.
12. [12] Pietras, R.J., Arboleda, J., Reese, D.M., Wongvipat, N., Pegram, M.D., Ramos, L., Gorman, C.M., Parker, M.G., Sliwkowski, M.X. and Slamon, D.J. (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells, Oncogene, 10, 2435-2446.
13. [13] Harant, H., Lindley, I., Uthman, A., Ballaun, C., Krupitza, G., Grunt, T., Huber, H. and Dittrich, C. (1995) Regulation of interleukin-8 gene expression by all-trans retinoic acid, Biochem. Biophys. Res. Commun., 210, 898-906.
14. [14] Hynes, N.B., Gerber, H.A., Saurer, S. and Groner, B. (1989) Overexpression of the c-erbB-2 protein in human breast tumor cell lines, J. Cell. Biochem., 39, 167-173.
15. erbB4 a fourth member of the epidermal growth factor receptor family, Proc. Natl. Acad. Sci. USA, 90, 1746-1750.
16. [16] Bacus, S.S., Kiguchi, K., Chin, D., King, C.R. and Huberman, E. (1990) Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER2/neu antigen, Mol. Carcinogenesis, 3, 350-362.
17. [17] Hudson, L.G., Santon, J.B., Glass, C.K. and Gill, G.N. (1990) Ligand-activated thyroid hormone and retinoic acid receptor inhibit growth factor receptor promoter expression, Cell, 62, 1165-1175.
18. [18] Zheng, Z.-S. and Goldsmith, L.A. (1990) Modulation of epidermal growth factor receptors by retinoic acid in ME180 cells, Cancer Res., 50, 1201-1205.
19. [19] Zheng, Z.-S., Polakowska, R., Johnson, A. and Goldsmith, L.A. (1992) Transcriptional control of epidermal growth factor receptor by retinoic acid, Cell Growth Differ., 3, 225-232.
20. [20] Pellegrini, R., Mariotti, A., Tagliabue, E., Bressan, R., Bunone, G., Coradini, D., Della Valle, G., Formelli, F., Cleris, L., Radice, P., Pierotti, M.A., Colnaghi, M.I. and Ménard, S. (1995) Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl)retinamide, Cell Growth Differ., 6, 863-869.
21. [21] Dawson, M.I., Chao, W.R., Pine, P., Jong, L., Hobbs, P.D., Rudd, C.K., Quick, T.C., Niles, R.M., Zhang, X.K., Lombarde, A., Ly, K.R., Shroot, B. and Fontana, J.A. (1995) Correlation of retinoid binding affinity to retinoic acid receptor α with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells, Cancer Res., 55, 4446-4451.
22. [22] van der Leede, B.J., Folkers, G.E., van den Brink, C.E., van der Saag, P.T. and van der Burg, B. (1995) Retinoic acid receptor alpha 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells, Mol. Cell. Endocrinol., 109, 77-86.
23. [23] Fry, D.W., Kraker, A.J., McMichael, A., Ambroso, L.A., Nelson, J.M., Leopold, W.R., Connors, R.W. and Bridges, A.J. (1994) A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science, 265, 1093-1095.
24. [24] Shepard, H.M., Lewis, G.D., Sarup, J.C., Fendly, B.M., Maneval, D., Mordenti, J., Figari, I., Kotts, C.E., Palladino, M.A. Jr., Ullrich, A. and Slamon, D. (1991) Monoclonal antibody therapy of human cancer: taking the HER2 proto-oncogene to the clinic, J. Clin. Immunol., 11, 117-127.
25. [25] Siegall, C.B. and Plowman, G.D. (1994) Activity of HER4 targeted ligand-toxin fusion proteins against human tumors (Abst. no. 2276), Proc. Am. Assoc. Cancer Res., 35, 382.
26. erbB2 Science, 256, 1205-1210.